Perceptions on Expected Outcomes of Immunotherapy in Advanced Non-small Cell Lung Cancer Patients With Poor Performance Status

Conditions: Non-small Cell Lung Cancer

Sex: All

Ages: 18 Years – N/A

Enrollment: 110

Sponsor: M.D. Anderson Cancer Center

Location: United States

Summary

To better understand your feelings and expectations about immunotherapy

Eligibility Criteria

Inclusion Criteria:Patients being considered for or within 2 months of starting immunotherapy for advanced NSCLCPatient ≥18 years of ageECOG ≥2Cognitively able to understand consent and complete questionnaire as determined by the interviewer at the time of study enrollmentEnglish speakingWilling to participate in the study and sign informed consentThe study will include the oncologists that treat non-small cell lung cancerExclusion Criteria:Treatment for curative intentPresence of Delirium (as determined by score >13 on MDAS 46, appendix A)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05634551). StuddyBuddy aggregates publicly available trial information.